India Globalization Capital announces that a life sciences presentation has been filed with the SEC on Form 8K. The presentation provides an overview of the Company’s initiatives in life sciences, including its focus on low-dose THC-based drug formulation and disease treatment and its various lines of cannabinoid-based consumer products.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on IGC:
- IGC Announces Updated Life Sciences Presentation
- Rising High: Exclusive talk with market research firm Brightfield Group
- IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion Act
- India Globalization Capital ‘applauds’ signing of cannabis research act
- Defense bill with marijuana reform attached is delayed, Marijuana Moment says